Cubist Systematic Strategies, LLC Seelos Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.66 - $1.22 $15,927 - $29,441	24,132 New	24,132 $28,000
Q4 2021 Feb 14, 2022	SELL	$1.59 - $2.38 $283,838 - $424,865	-178,515 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.69 - $2.89 $31,290 - $53,508	18,515 Added 11.57%	178,515 $430,000
Q2 2021 Aug 16, 2021	BUY	$2.64 - $6.32 $282,480 - $676,240	107,000 Added 201.89%	160,000 $422,000
Q1 2021 May 17, 2021	BUY	$1.35 - $4.99 $71,550 - $264,470	53,000 New	53,000 $264,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $59.7M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.